KRAS (n = 17), HRAS (n = 20), BRAF (n = 19), and MAP2K1 (n = 16) were among the 150 putative driver genes recurrently mutated in DLBCL identified in the study [14]. This evidence concerns the gene KRAS and diffuse large B-cell lymphoma.